UPDATE: StepStone Group (STEP) PT Raised to $48 at Morgan Stanley After 62% Earnings Beat
- Dow, S&P post worst week in months after hawkish Fed spooks investors
- Fed-fueled dollar rises as bears make for exits
- Adobe (ADBE) Edges Higher After Topping Q2 Estimates, Analysts Raise PT on 'Impressive' Performance
- Fed Statement Very Bullish for Tech Stocks, Focus on Cloud and Cyber Stocks - Wedbush
- You Fight Real Physical Inflation With Rate Hikes, Not Talk of Rate Hikes; Buy the Dip in Commodities, Gold Underpriced - Goldman Sachs
Morgan Stanley analyst Michael Cyprys raised the price target on StepStone Group (NASDAQ: STEP) to $48.00 (from $47.00) after the company reported a 62% earnings beat in C4Q20 that demonstrates embedded earnings power playing out over the next several years. Upside can come from execution on strong client asset growth driving topline management fee growth, margin
expansion, and performance fee generation.
The analyst reiterated the Overweight rating, stating "STEP's 62% earnings beat in C4Q20 demonstrates embedded earnings power that should play out over the next several years as management executes on strong client asset growth driving topline management fee growth, margin expansion, and performance fee generation. Over the next 5 years, we think STEP can deliver 18% EPS CAGR to $1.60, supported by 15% fee-paying AUM CAGR and 18% EBITDA CAGR to $213m (after NCI). This is not reflected in current valuation, with the shares trading at 27x CY2022 EBITDA. Our $48 price target for 28% upside is derived from a 5-yr discounted EV/EBITDA approach".
You May Also Be Interested In
- Commercial Metals Company (CMC) PT Raised to $34 at BMO Capital
- SThree Plc. (STHR:LN) (STREF) PT Raised to GBP5.40 at Jefferies
- Evertz Technology (ET:CN) (EVTZF) PT Raised to Cdn$16.50 at Canaccord Genuity
Create E-mail Alert Related CategoriesAnalyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT Change
Related EntitiesMorgan Stanley, Earnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!